It's suffering hugely now on sentiment loss alone. I think the market is pricing in apathy, very small volume and given the bods dire communication history it's unlikely we'll see an RNS until they have absolutely no alternative but to release one. Clinicaltrials.gov still shows "not yet recruiting", I am going to have to top up to bring my crazy average down at some point. Last bought at .38 thinking it couldn't go any lower......frustrated with this one.
Thats my philosophy. Sentiment rock bottom. Buy as many as you can. What on earth is the market pricing in? Massive dilution? Cataclysmic failure?
I repeat Just £20m MC for a company with a potential multi-billion value drug going into PIII trials. Perhaps people don't believe it anymore, I don't know, but I believe it will happen and buying in at this rock bottom price will make my gains that more substantial in percentage terms. An opportunity too good to miss.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.